This site is for United States residents 18 years of age or older.

If you have CML or Ph+ ALL
and you want to learn more,
you've come to the right place.

For people with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), who cannot receive any other TKI medicines or have a T315I mutation.

FOR CML

Learn about CML and what you may experience with ICLUSIG.

FOR Ph+ ALL

Learn what Ph+ ALL is
and how ICLUSIG can help treat it.

Support when you need it

Takeda Oncology Support Program is here to help you access and pay for ICLUSIG, and to answer questions about treatment.

LEARN MORE

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about ICLUSIG® (ponatinib)?

ICLUSIG can cause serious side effects, including:

Blood clots or blockage in your blood vessels (arteries and veins). Blood clots or blockage in your blood vessels may lead to heart attack, stroke, or death. A blood clot or blockage in your blood vessels can prevent proper blood flow to your heart, brain, bowels (intestines), legs, eyes, and other parts of your body. You may need emergency surgery or treatment in a hospital. Get medical help right away if you get any of the following symptoms:

chest pain or pressure
pain in your arms, legs, back, neck or jaw
shortness of breath
numbness or weakness on one side of your body
leg swelling
trouble talking
headache
dizziness
severe stomach area pain
decreased vision or loss of vision

Blood clots or blockage in your blood vessels can happen in people with or without risk factors for heart and blood vessel disease, including people 50 years of age or younger. The most common risk factors for these problems are a history of high blood pressure (hypertension), high levels of fat in the blood (hyperlipidemia), and heart disease. Blood clots or blockages in your blood vessels happen more often in people as they get older, and in people with a past history of decreased blood flow, high blood pressure, diabetes, or high levels of fats in the blood.

INDICATION

ICLUSIG® (ponatinib) is a prescription medicine used to treat adults who have:

chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) who cannot receive any other tyrosine kinase inhibitor (TKI) medicines
a specific type of abnormal gene (T315I-positive) chronic phase, accelerated phase, or blast phase CML, or T315I-positive Ph+ ALL

ICLUSIG is not for use to treat people with newly diagnosed chronic phase CML.

It is not known if ICLUSIG is safe and effective in children less than 18 years of age.

Heart problems. ICLUSIG can cause heart problems, including heart failure which can be serious and may lead to death. Heart failure means your heart does not pump blood well enough. ICLUSIG can also cause irregular slow or fast heartbeats and heart attack. Your healthcare provider will check you for heart problems during your treatment with ICLUSIG. Get medical help right away if you get any of the following symptoms: shortness of breath, chest pain, fast or irregular heartbeats, dizziness, or feel faint.

Liver problems. ICLUSIG can cause liver problems, including liver failure, which can be severe and may lead to death. Your healthcare provider will do blood tests before and during your treatment with ICLUSIG to check for liver problems. Get medical help right away if you get any of these symptoms of liver problems during treatment:

yellowing of your skin or the white part of your eyes (jaundice)
dark "tea-colored" urine
sleepiness
loss of appetite
bleeding or bruising

See "What are the possible side effects of ICLUSIG?" for information about side effects.

What is ICLUSIG?

ICLUSIG is a prescription medicine used to treat adults who have:

chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) who cannot receive any other tyrosine kinase inhibitor (TKI) medicines
a specific type of abnormal gene (T315I-positive) chronic phase, accelerated phase, or blast phase CML, or T315I-positive Ph+ ALL

ICLUSIG is not for use to treat people with newly diagnosed chronic phase CML.

It is not known if ICLUSIG is safe and effective in children less than 18 years of age.

Before you take ICLUSIG, tell your healthcare provider about all of your medical conditions, including if you:

have a history of blood clots in your blood vessels (arteries or veins)
have heart problems, including heart failure, irregular heartbeats, and QT prolongation
have diabetes
have a history of high cholesterol
have liver problems
have had inflammation of your pancreas (pancreatitis)
have high blood pressure
are pregnant or plan to become pregnant. ICLUSIG can harm your unborn baby.
- Your healthcare provider will do a pregnancy test before you start taking ICLUSIG.
- You should not become pregnant during treatment with ICLUSIG.
- For females who can become pregnant:
  - — Use an effective form of birth control during treatment and for 3 weeks after your last dose of ICLUSIG.
  - — Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with ICLUSIG.
  - — ICLUSIG may affect your ability to have children. Tell your healthcare provider if this is a concern for you.
are breastfeeding or plan to breastfeed. It is not known if ICLUSIG passes into your breast milk. Do not breastfeed during treatment and for 6 days after your last dose of ICLUSIG.
have bleeding problems
plan to have surgery or have had a recent surgery. You should stop taking ICLUSIG at least 1 week before any planned surgery. See "What are the possible side effects of ICLUSIG?"
are lactose (milk sugar) intolerant. ICLUSIG tablets contain lactose.
drink grapefruit juice

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. ICLUSIG and other medicines may affect each other causing side effects.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take ICLUSIG?

Take ICLUSIG exactly as your healthcare provider tells you to take it.
Swallow ICLUSIG tablets whole. Do not crush or dissolve ICLUSIG tablets.
You may take ICLUSIG with or without food.
If you miss a dose of ICLUSIG, take your next dose at your regular time. Do not take 2 doses at the same time to make up for a missed dose.
If you take too much ICLUSIG, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of ICLUSIG?

ICLUSIG may cause serious side effects, including:

See "What is the most important information I should know about ICLUSIG?"
High blood pressure. Your blood pressure should be checked regularly and any high blood pressure should be treated while you are taking ICLUSIG. Tell your healthcare provider if you get confusion, headaches, dizziness, chest pain or shortness of breath.
Inflammation of the pancreas (pancreatitis). Tell your healthcare provider if you get any of the following symptoms: sudden stomach-area pain or discomfort, nausea, and vomiting. Your healthcare provider should do blood tests to check for pancreatitis during treatment with ICLUSIG.
Neuropathy. ICLUSIG may cause damage to the nerves in your arms, brain, hands, legs, or feet (neuropathy). Tell your healthcare provider if you get any of these symptoms during treatment with ICLUSIG:
- — muscle weakness, tingling, burning, pain, and loss of feeling in your hands and feet
- — double vision and other problems with eyesight, trouble moving the eye, drooping of part of the face, sagging or drooping eyelids, and change in taste
Effects on the eye. Serious eye problems that can lead to blindness or blurred vision may happen with ICLUSIG. Tell your healthcare provider if you get any of the following symptoms: bleeding in the eye, perceived flashes of light, light sensitivity, floaters, dry inflamed, swollen, or itchy eyes, and eye pain. Your healthcare provider will monitor your vision before and during your treatment with ICLUSIG.
Severe bleeding. ICLUSIG can cause bleeding which can be serious and may lead to death. Tell your healthcare provider if you get any signs of bleeding during treatment with ICLUSIG including:
- — vomiting blood or if your vomit looks like coffee-grounds
- — pink or brown urine
- — red or black (looks like tar) stools
- — coughing up blood or blood clots
- — unusual bleeding or bruising of your skin
- — menstrual bleeding that is heavier than normal
- — unusual vaginal bleeding
- — nose bleeds that happen often
- — drowsiness or difficulty being awakened
- — confusion
- — headache
- — change in speech
Fluid retention. Your body may hold too much fluid (fluid retention). Tell your healthcare provider right away if you get any of these symptoms during treatment with ICLUSIG:
- — swelling of your hands, ankles, feet, face, or all over your body
- — weight gain
- — shortness of breath and cough
Irregular heartbeat. ICLUSIG may cause an irregular heartbeat. Tell your healthcare provider right away if you experience loss of consciousness, fainting, dizziness, chest pain or palpitations.
Low blood cell counts. ICLUSIG may cause low blood cell counts, which can be severe. Your healthcare provider will check your blood counts regularly during treatment with ICLUSIG. Tell your healthcare provider right away if you have a fever or any signs of an infection while taking ICLUSIG.
Tumor Lysis Syndrome (TLS). TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have:
- — kidney failure and the need for dialysis treatment
- — an abnormal heartbeat

Your healthcare provider may do blood tests to check for TLS.

Reversible Posterior Leukoencephalopathy Syndrome (RPLS – also known as Posterior Reversible Encephalopathy Syndrome - PRES). ICLUSIG may trigger a condition called RPLS. Call your healthcare provider right away if you get headaches, seizures, confusion, changes in vision or problems thinking.
Wound healing problems. Wound healing problems have happened in some people who take ICLUSIG. Tell your healthcare provider if you plan to have any surgery before or during treatment with ICLUSIG.
- — You should stop taking ICLUSIG at least 1 week before planned surgery.
- — Your healthcare provider should tell you when you may start taking ICLUSIG again after surgery.
A tear in your stomach or intestinal wall (perforation). Tell your healthcare provider right away if you get:
- — severe pain in your stomach-area (abdomen)
- — swelling of the abdomen
- — high fever

The most common side effects of ICLUSIG include:

stomach-area (abdomen) pain
skin rash
constipation
headache
dry skin
blood clots or blockage in blood vessels (arteries)
tiredness
high blood pressure
fever
joint pain
nausea
diarrhea
increase in lipase levels (a blood test done to check your pancreas)
vomiting
muscle pain
pain in arms, hands, legs, and feet

Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with ICLUSIG if you have certain side effects.
Talk to your doctor if you have a side effect that bothers you or does not go away. These are not all of the possible side effects of ICLUSIG. For more information, ask your healthcare provider or pharmacist.

To report SUSPECTED ADVERSE REACTIONS, contact Takeda at 1-844-817-6468 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please read the Medication Guide in the full Prescribing Information, including Important Serious Side Effects.

The information provided on this site is intended for informational purposes and cannot replace individualized guidance from a healthcare provider. Be sure to talk with your healthcare provider about making any change to your healthcare regimen. The information on this site is intended for residents of the United States only. Product labeling may be different in other countries.

If you have CML or Ph+ ALL and you want to learn more, you've come to the right place.